520 related articles for article (PubMed ID: 8394922)
1. Systemic hemodynamics, renal function and hormonal levels during inhibition of neutral endopeptidase 3.4.24.11 and angiotensin-converting enzyme in conscious dogs with pacing-induced heart failure.
Seymour AA; Asaad MM; Lanoce VM; Langenbacher KM; Fennell SA; Rogers WL
J Pharmacol Exp Ther; 1993 Aug; 266(2):872-83. PubMed ID: 8394922
[TBL] [Abstract][Full Text] [Related]
2. Determinants of in vivo activity of neutral endopeptidase 3.4.24.11 and angiotensin converting enzyme inhibitors.
Seymour AA; Asaad MM; Abboa-Offei BE; Smith PL; Rogers WL; Dorso CR
J Pharmacol Exp Ther; 1996 Feb; 276(2):708-13. PubMed ID: 8632340
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of neutral endopeptidase 3.4.24.11 in conscious dogs with pacing induced heart failure.
Seymour AA; Asaad MM; Lanoce VM; Fennell SA; Cheung HS; Rogers WL
Cardiovasc Res; 1993 Jun; 27(6):1015-23. PubMed ID: 8221758
[TBL] [Abstract][Full Text] [Related]
4. Potentiation of the renal responses to bradykinin by inhibition of neutral endopeptidase 3.4.24.11 and angiotensin-converting enzyme in anesthetized dogs.
Seymour AA; Sheldon JH; Smith PL; Asaad M; Rogers WL
J Pharmacol Exp Ther; 1994 Apr; 269(1):263-70. PubMed ID: 8169834
[TBL] [Abstract][Full Text] [Related]
5. Hemodynamic, renal, and hormonal effects of rapid ventricular pacing in conscious dogs.
Seymour AA; Burkett DE; Asaad MM; Lanoce VM; Clemons AF; Rogers WL
Lab Anim Sci; 1994 Oct; 44(5):443-52. PubMed ID: 7844952
[TBL] [Abstract][Full Text] [Related]
6. Blockade of the renin-angiotensin system in heart failure in conscious dogs.
Murakami M; Suzuki H; Naitoh M; Matsumoto A; Kageyama Y; Tsujimoto G; Saruta T
J Hypertens; 1995 Dec; 13(12 Pt 1):1405-12. PubMed ID: 8866902
[TBL] [Abstract][Full Text] [Related]
7. Effects of alatriopril, a mixed inhibitor of atriopeptidase and angiotensin I-converting enzyme, on cardiac hypertrophy and hormonal responses in rats with myocardial infarction. Comparison with captopril.
Bralet J; Marie C; Mossiat C; Lecomte JM; Gros C; Schwartz JC
J Pharmacol Exp Ther; 1994 Jul; 270(1):8-14. PubMed ID: 8035346
[TBL] [Abstract][Full Text] [Related]
8. Potentiation of brain natriuretic peptides by SQ 28,603, an inhibitor of neutral endopeptidase 3.4.24.11, in monkeys and rats.
Seymour AA; Asaad MM; Abboa-Offei BE; Rovnyak PL; Fennell S; Rogers WL
J Pharmacol Exp Ther; 1992 Jul; 262(1):60-70. PubMed ID: 1385630
[TBL] [Abstract][Full Text] [Related]
9. Combined angiotensin-converting enzyme inhibition and adrenomedullin in an ovine model of heart failure.
Rademaker MT; Charles CJ; Cooper GJ; Coy DH; Espiner EA; Lewis LK; Nicholls MG; Richards AM
Clin Sci (Lond); 2002 Jun; 102(6):653-60. PubMed ID: 12049620
[TBL] [Abstract][Full Text] [Related]
10. Combined inhibition of neutral endopeptidase and angiotensin converting enzyme in cardiomyopathic hamsters with compensated heart failure.
Trippodo NC; Fox M; Natarajan V; Panchal BC; Dorso CR; Asaad MM
J Pharmacol Exp Ther; 1993 Oct; 267(1):108-16. PubMed ID: 8229737
[TBL] [Abstract][Full Text] [Related]
11. Potentiation of natriuretic peptides by neutral endopeptidase inhibitors.
Seymour AA; Abboa-Offei BE; Smith PL; Mathers PD; Asaad MM; Rogers WL
Clin Exp Pharmacol Physiol; 1995 Jan; 22(1):63-9. PubMed ID: 7768036
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin inhibition potentiates the renal responses to neutral endopeptidase inhibition in dogs with congestive heart failure.
Margulies KB; Perrella MA; McKinley LJ; Burnett JC
J Clin Invest; 1991 Nov; 88(5):1636-42. PubMed ID: 1658047
[TBL] [Abstract][Full Text] [Related]
13. Urocortin 2 combined with angiotensin-converting enzyme inhibition in experimental heart failure.
Rademaker MT; Charles CJ; Nicholls MG; Richards AM
Clin Sci (Lond); 2008 May; 114(10):635-42. PubMed ID: 18052934
[TBL] [Abstract][Full Text] [Related]
14. [Systemic and regional hemodynamic effects of a new angiotensin converting enzyme and neutral endopeptidase mixed inhibitor, alatriopril, in the dog].
Richard V; Lecomte JM; Thuillez C
Arch Mal Coeur Vaiss; 1993 Aug; 86(8):1275-9. PubMed ID: 8129543
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of both angiotensin-converting enzyme and neutral endopeptidase by S21402 (RB105) in rats with experimental myocardial infarction.
Gonzalez W; Beslot F; Laboulandine I; Fournié-Zaluski MC; Roques BP; Michel JB
J Pharmacol Exp Ther; 1996 Aug; 278(2):573-81. PubMed ID: 8768706
[TBL] [Abstract][Full Text] [Related]
16. Effect of low dose aspirin on cardiorenal function and acute hemodynamic response to enalaprilat in a canine model of severe heart failure.
Evans MA; Burnett JC; Redfield MM
J Am Coll Cardiol; 1995 May; 25(6):1445-50. PubMed ID: 7722147
[TBL] [Abstract][Full Text] [Related]
17. Possible regulation of atrial natriuretic factor by neutral endopeptidase 24.11 and clearance receptors.
Seymour AA; Norman JA; Asaad MM; Fennell SA; Abboa-Offei B; Little DK; Kratunis VJ; Delaney NG; Hunt JT; Di Donato G
J Pharmacol Exp Ther; 1991 Mar; 256(3):1002-9. PubMed ID: 1826031
[TBL] [Abstract][Full Text] [Related]
18. Hypotensive and natriuretic effects of RB 105, a new dual inhibitor of angiotensin converting enzyme and neutral endopeptidase in hypertensive rats.
Gonzalez Vera W; Fournié-Zaluski MC; Pham I; Laboulandine I; Roques BP; Michel JB
J Pharmacol Exp Ther; 1995 Jan; 272(1):343-51. PubMed ID: 7815350
[TBL] [Abstract][Full Text] [Related]
19. Marked difference between angiotensin-converting enzyme and neutral endopeptidase inhibition in vivo by a dual inhibitor of both enzymes.
Anastasopoulos F; Leung R; Kladis A; James GM; Briscoe TA; Gorski TP; Campbell DJ
J Pharmacol Exp Ther; 1998 Mar; 284(3):799-805. PubMed ID: 9495836
[TBL] [Abstract][Full Text] [Related]
20. Effects of the dual metallopeptidase inhibitor, MDL 100,240, on regional haemodynamic responses to vasoactive peptides in conscious rats.
Gardiner SM; Kemp PA; Brunner-Ferber F; Bennett T
Br J Pharmacol; 1997 Dec; 122(8):1687-93. PubMed ID: 9422815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
